Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients-Reference-Cited by-同舟云学术

Overexpression of P‐glycoprotein and resistance to Imatinib in chronic myeloid leukemia patients

Published:2020-07-26 Issue:9 Volume:34 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Ammar Mariam¹^ORCID,Louati Nour²,Frikha Imen³,Medhaffar Moez³,Ghozzi Hanen¹,Elloumi Moez³,Menif Hela²,Zeghal Khaled¹,Ben Mahmoud Lobna¹^ORCID

Affiliation:

1. Department of Pharmacology, Faculty of Medicine University of Sfax Sfax Tunisia

2. Sfax Regional Center of Blood Transfusion Sfax Tunisia

3. Department of Clinical Hematology Hedi Chaker Hospital, University of Sfax Sfax Tunisia

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry, medical,Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23374

Reference38 articles.

1. Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

2. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

3. Chronic Myelogenous Leukemia: Biology and Therapy

4. Association of MDR1 gene polymorphism (G2677T) with chronic myeloid leukemia;Sailaja K;Biol Med,2010

5. Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment;International Journal of Molecular Sciences;2024-09-11

2. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09

3. Overcoming flumatinib resistance in chronic myeloid leukaemia: Insights into cellular mechanisms and ivermectin's therapeutic potential;Journal of Cellular and Molecular Medicine;2024-07

4. Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein;Scientific Reports;2024-01-02

5. Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia;International Journal of Biological Sciences;2024